Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

422 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Experience of indinavir/ritonavir 400/100 mg twice-daily highly active antiretroviral therapy-containing regimen in HIV-1-infected patients in Bamako, Mali: the NOGOMA Study.
Canestri A, Cisse M, Marcelin AG, Peytavin G, Traore E, Assoumou L, Traore O, Koita V, Diallo F, Sangare AT, Sidibé MK, Calvez V, Sylla A, Katlama C, Tubiana R. Canestri A, et al. Among authors: cisse m. J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):477-9. doi: 10.1097/QAI.0b013e318061b5c3. J Acquir Immune Defic Syndr. 2007. PMID: 17622837 Clinical Trial. No abstract available.
Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.
Derache A, Maiga AI, Traore O, Akonde A, Cisse M, Jarrousse B, Koita V, Diarra B, Carcelain G, Barin F, Pizzocolo C, Pizarro L, Katlama C, Calvez V, Marcelin AG. Derache A, et al. Among authors: cisse m. J Antimicrob Chemother. 2008 Sep;62(3):456-63. doi: 10.1093/jac/dkn234. Epub 2008 Jun 13. J Antimicrob Chemother. 2008. PMID: 18556706
Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naïve patients infected with non-B HIV-1 subtypes.
Maïga AI, Descamps D, Morand-Joubert L, Malet I, Derache A, Cisse M, Koita V, Akonde A, Diarra B, Wirden M, Tounkara A, Verlinden Y, Katlama C, Costagliola D, Masquelier B, Calvez V, Marcelin AG. Maïga AI, et al. Among authors: cisse m. Antimicrob Agents Chemother. 2010 Feb;54(2):728-33. doi: 10.1128/AAC.01335-09. Epub 2009 Dec 14. Antimicrob Agents Chemother. 2010. PMID: 20008779 Free PMC article.
High level of primary drug resistance in Mali.
Haidara A, Chamberland A, Sylla M, Aboubacrine SA, Cissé M, Traore HA, Maiga MY, Tounkara A, Nguyen VK, Tremblay C; Appuyer le Traitement Anti Rétroviral en Afrique de l'Ouest (ATARAO) Group 1. Haidara A, et al. Among authors: cisse m. HIV Med. 2010 Jul 1;11(6):404-11. doi: 10.1111/j.1468-1293.2009.00806.x. Epub 2010 Feb 8. HIV Med. 2010. PMID: 20146734 Free article.
Transmitted antiretroviral drug resistance in newly HIV-infected and untreated patients in Ségou and Bamako, Mali.
Maiga AI, Fofana DB, Maiga AC, Diallo F, Ait-Arkoub Z, Daou F, Cisse M, Sarro YD, Oumar AA, Sylla A, Katlama C, Taiwo B, Murphy R, Tounkara A, Marcelin AG, Calvez V. Maiga AI, et al. Among authors: cisse m. AIDS Res Hum Retroviruses. 2013 Jan;29(1):182-6. doi: 10.1089/AID.2012.0118. Epub 2012 Aug 27. AIDS Res Hum Retroviruses. 2013. PMID: 22823755 Free PMC article.
422 results